Tremfya patent lentigen technology, inc?

I can help, but I need one clarification: do you mean Tremfya’s (guselkumab) original patent and whether it involves “Lentigen Technology, Inc.”, or are you asking about a specific patent/licensing agreement?

That said, here’s what I can say at a high level:

• Tremfya (guselkumab) is an IL‑23 inhibitor biologic originally developed by Janssen (J&J).
• “Lentigen Technology, Inc.” is a company name used in the biologics/patent ecosystem, often connected to platform-related technologies (for example, antibody discovery/engineering, or related IP), but Tremfya’s core IL‑23 antibody program is mainly associated with Janssen and its partners.
• Without a specific patent number, application number, or link, it’s hard to confirm exactly which Tremfya-related patent(s) cite Lentigen Technology, Inc. as an assignee/inventor/licensor.

If you share any of the following, I can pinpoint the answer

1. The US/EU/WO patent number (or publication number) you’re looking at
2. A link to the patent record
3. The exact wording you saw (e.g., “assignee: Lentigen Technology, Inc.”)

Quick question

Can you paste the patent number (or the text snippet) where you saw “Lentigen Technology, Inc.”?